Zacks Investment Research
20 Jul 2026, 23:16 UTC · 9h ago
Here's Why Pacific Biosciences of California (PACB) Fell More Than Broader Market
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Zacks Investment Research
20 Jul 2026, 23:16 UTC · 9h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
4 claims · each scored for market impact
Pacific Biosciences of California (PACB) is expected to report an EPS of -$0.14 for the upcoming quarter on August 5, 2026, a 7.69% decline year-over-year. — A projected increase in losses per share typically exerts downward pressure on a stock price ahead of earnings.
-0.40Pacific Biosciences' revenue for the upcoming quarter is estimated at $40.7 million, representing a 2.34% increase from the same period last year. — Modest revenue growth is a positive signal, though likely overshadowed by the projected increase in losses.
+0.20PACB closed at $1.36 in the latest session, falling 5.56% and underperforming the S&P 500, Dow, and Nasdaq. — Significant single-day underperformance relative to broad indices suggests negative short-term sentiment.
-0.20Continue reading
6 related stories
Top 2 movers · tap to explore
Pacific Biosciences currently holds a Zacks Rank of #3 (Hold), with consensus EPS projections remaining stagnant over the last 30 days. — A 'Hold' rating and stagnant estimates indicate a lack of immediate catalyst for significant price movement.
+0.00Which stocks this story touches
The company's stock price recently declined, and analysts expect a fall in earnings per share compared to the previous year.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Benzinga
2h ago
